Daneen Pharma products and prices in Pakistan
Manufacturer Holds a DRAP Drug Manufacturing Licence (DML) for its products. Source: DRAP.
Follow price changes 🔒 Company report (Pharma Pro)Private pharmaceutical manufacturer · Lahore · Pakistan
Lahore-based branded-generics pharmaceutical manufacturer with a modern manufacturing facility at Sundar Industrial Estate.
Daneen Pharma products in Pakistan
Daneen Pharma (Pvt) Ltd has 93 medicine presentations registered in Pakistan under 33 brands, covering 33 generic medicines. Most of its products are in Anti-infectives, CNS & mental health and Cardiovascular. Its brands with the most registered strengths and packs are Nadsar-A (Telmisartan + Amlodipine), Saltam (Levetiracetam), Blucef (Ceftriaxone) and Xinther (Clarithromycin). 93 products have an official DRAP price on MedInfoBase. See all 33 brands A to Z
What is sourced, and how recent is it?
Regulatory-source portfolio data and company-supplied/corporate profile fields are tracked separately. Company claim/verification status is separate from source quality. An unclaimed company can still have a fully official-source-observed portfolio.
Company profile
- Legal / official name
- Daneen Pharma (Private) Limited
- Company type
- Private pharmaceutical manufacturer
- Address
- 27, Sundar Industrial Estate, Sundar, Raiwind Road, Lahore 53801, Pakistan · 53801
- Website
- daneenpharma.com ↗
- Phone
- +92 21 111 10 10 11
- Official contact
- Contact page ↗
- Corporate source details checked
- 16 Aug 2026
- Corporate profile completeness
- 88%
Company location
A sourced company location is recorded. Use the map link below for directions.
Portfolio at a glance
RegistrationA unique regulatory registration number. One registration may have more than one strength/form/pack presentation.
PresentationA distinct medicine presentation, such as a particular strength, dosage form and pack.
IndexedA canonical MedInfoBase presentation that passed MedInfoBase identity and publication controls.
Source observedAn additional presentation observed in an official DRAP source but not counted as an indexed MedInfoBase presentation.
Registry onlyAn exact registry-verified registration not otherwise represented by an indexed or source-observed presentation.
Registry verifiedAn exact registration match found in an official DRAP registry source. This is evidence status, not a commercial ranking.
How complete is this profile?
Downloadable company intelligence charts
Copy or download any chart as a presentation-ready PNG. Every exported chart keeps MedInfoBase attribution and the source company-profile URL.
Therapeutic Portfolio Mix
Shows where the company portfolio is concentrated across broad therapeutic areas.
Portfolio distribution, not sales or market-share data.
Dosage Form Portfolio
Shows how the company portfolio is distributed across tablets, capsules, injections, liquids and other forms.
Counts are product presentations, not production or sales volumes.
Equivalent Price Position
Shows whether safely comparable products are below, near or above the peer median unit price.
This is price-position intelligence, not sales, demand or market-share data.
Closest Portfolio Competitors
Highlights other manufacturers with the greatest generic overlap with this company portfolio.
Competitor ranking is based on shared generics in MedInfoBase, not commercial sales performance.
Therapeutic areas
High-level clinical areas represented by this company’s current MedInfoBase portfolio.
Drug classes
More specific classes derived from the canonical generic and preserved curated classifications.
Dosage forms
How MedInfoBase classifies the portfolio
MedInfoBase uses a two-level taxonomy. Therapeutic area is a broad portfolio category, while drug class is the more specific pharmacological or clinical class. Existing curated classifications are preserved. Blank records are assigned conservatively from the canonical generic name and, when available, ATC information. Multi-use medicines may be placed in a cross-therapeutic category rather than forced into a single indication.
Deepest brand families
Unit-price positioning vs equivalent products
See where M/s Daneen Pharma (Pvt) Ltd is priced against the market
83 of its products have like-for-like competitors. Pharma Pro shows how many are priced below, near or above the market median, the company's overall price position, and product-by-product examples.
How MedInfoBase calculates price position
Only current prices with safely interpretable pack quantities are used. A product is compared only with the same generic, same stated strength, same dosage form and a compatible unit basis such as tablet, capsule, mL or gram. These are database-derived price comparisons, not sales or market-share estimates.
Portfolio overlap
Companies sharing the largest number of generics with this portfolio. This measures product overlap, not commercial performance.
🔒 3 more overlapping companies, with shared-generic detail, in Pharma Pro. Unlock
Observed database signals
These dates describe records observed by MedInfoBase. They should not be interpreted as product launch dates or sales activity.
Medicine portfolio
This unified portfolio keeps three evidence lanes distinct: indexed MedInfoBase presentations, additional source-observed presentations, and registry-only registrations that are not otherwise represented. A registration number is not the same thing as a presentation, and source-observed rows are not counted as indexed. Source-only rows with a strength/form/pack contradiction remain visible as evidence but the conflicting field is held for normalization.
| Brand | Generic | Strength | Form | Pack | Registration | Source-listed price | Unit price | Price position |
|---|---|---|---|---|---|---|---|---|
| Ardan | Artesunate | 30 mg | Powder for injection | 1's | 100732 | PKR 132.96 | PKR 132.96/vial/unit | No comparator |
| Ardan | Artesunate | 60 mg | Powder for injection | 1's | 100733 | PKR 221.59 | PKR 221.59/vial/unit | No comparator |
| Ardan | Artesunate | 120 mg | Powder for injection | 1's | 100734 | PKR 369.31 | PKR 369.31/vial/unit | No comparator |
| Bilat 10mg OD TabletRegistry verified | Bilastine | — | — | — | 136639Official source ↗ | No indexed price | — | — |
| Bilat 2.5mg/ml Oral SolutionRegistry verified | Bilastine | — | — | — | 136637Official source ↗ | No indexed price | — | — |
| Bilat 20mg OD TabletRegistry verified | Bilastine | — | — | — | 136640Official source ↗ | No indexed price | — | — |
| Bilat 20mg TabletRegistry verified | Bilastine | — | — | — | 136638Official source ↗ | No indexed price | — | — |
| Blucef | Ceftriaxone | 250 mg | IV injection | 1's | 064692 | PKR 196.09 | PKR 196.09/vial/unit | 🔒 Pharma Pro |
| Blucef | Ceftriaxone | 1 g | IV injection | 1's | 064693 | PKR 623.22 | PKR 623.22/vial/unit | 🔒 Pharma Pro |
| Blucef | Ceftriaxone | 500 mg | IV injection | 1's | 064695 | PKR 330.04 | PKR 330.04/vial/unit | 🔒 Pharma Pro |
| Blucef | Ceftriaxone | 250 mg | IM injection | 1's | 067709 | PKR 196.09 | PKR 196.09/vial/unit | 🔒 Pharma Pro |
| Blucef | Ceftriaxone | 500 mg | IM injection | 1's | 067710 | PKR 330.04 | PKR 330.04/vial/unit | 🔒 Pharma Pro |
| Blucef | Ceftriaxone | 2 g | Injection | 1's | 119584 | PKR 929.36 | PKR 929.36/vial/unit | 🔒 Pharma Pro |
| Canon | Vancomycin | 500 mg | Powder for injection | 1's | 099131 | PKR 1,292.61 | PKR 1,292.61/vial/unit | No comparator |
| Confentrin | Artemether + Lumefantrine | 120 mg + 120 mg | Tablet | 16's | 108371 | PKR 660.89 | PKR 41.31/tablet | 🔒 Pharma Pro |
| ConfentrinSource observed | Artemether + Lumefantrine | 80 mg | Tablet | 8's | 108372Official source ↗ | No indexed price | — | — |
| Confentrin | Artemether + Lumefantrine | 40 mg + 240 mg | Tablet | 8's | 110803 | PKR 601.53 | PKR 75.19/tablet | 🔒 Pharma Pro |
| Danclave | Aciclovir | 200 mg | Tablet | 10's | 106998 | PKR 426.55 | PKR 42.66/tablet | 🔒 Pharma Pro |
| Danclave | Aciclovir | 800 mg | Tablet | 20's | 106999 | PKR 1,535.57 | PKR 76.78/tablet | 🔒 Pharma Pro |
| Danclave | Aciclovir | 400 mg | Tablet | 35's | 107000 | PKR 2,388.66 | PKR 68.25/tablet | 🔒 Pharma Pro |
| Daneso 20mg CapsuleRegistry verified | Esomeprazole Magnesium Trihydrate enteric coated pellets 22.5% eq. to Esomeprazole | — | — | — | 124000Official source ↗ | No indexed price | — | — |
| Daneso 40mg CapsuleRegistry verified | Esomeprazole Magnesium Trihydrate enteric coated pellets 22.5% eq. to Esomeprazole | — | — | — | 124001Official source ↗ | No indexed price | — | — |
| Daneso 40mg Powder for Injection/InfusionRegistry verified | Esomeprazole Sodium eq. to Esomeprazole | — | — | — | 123568Official source ↗ | No indexed price | — | — |
| Danletro | Letrozole | 2.5 mg | Tablet | 10's | 110601 | PKR 4,931.75 | PKR 493.18/tablet | 🔒 Pharma Pro |
| Danletro | Letrozole | 2.5 mg | Tablet | 30's | 110601 | PKR 14,795.25 | PKR 493.18/tablet | 🔒 Pharma Pro |
| Dolketo-T Tablet 25mg/75mgRegistry verified | Dexketoprofen Trometamol, Tramadol Hydrochloride | — | — | — | 134165Official source ↗ | No indexed price | — | — |
| Dprofen | Ibuprofen | 600 mg/100 mL | IV infusion | 100ml Vial | 123712 | PKR 271.62 | PKR 2.72/mL | 🔒 Pharma Pro |
| Drisper Disintegranting | Risperidone | 4 mg | Tablet | 10's | 124314 | PKR 805.45 | PKR 80.55/tablet | 🔒 Pharma Pro |
| Ekzalt 1gm InjectionRegistry verified | Cefepime hydrochloride with L-arginine eq. to Cefepime | — | — | — | 069311Official source ↗ | No indexed price | — | — |
| Ekzalt 2gm InjectionRegistry verified | Cefepime | — | — | — | 132486Official source ↗ | No indexed price | — | — |
| Ekzalt Injection 500mgRegistry verified | Cefepime (as HCl) | — | — | — | 064706Official source ↗ | No indexed price | — | — |
| Erbivir | Entecavir | 0.5 mg | Tablet | 30's | 102413 | PKR 9,098.12 | PKR 303.27/tablet | 🔒 Pharma Pro |
| Erbivir | Entecavir | 0.5 mg | Tablet | 10's | 102413 | PKR 3,296.15 | PKR 329.62/tablet | 🔒 Pharma Pro |
| Erbivir | Entecavir | 1 mg | Tablet | 30's | 102414 | PKR 15,162.32 | PKR 505.41/tablet | 🔒 Pharma Pro |
| Erbivir | Entecavir | 1 mg | Tablet | 10's | 102414 | PKR 5,493.59 | PKR 549.36/tablet | 🔒 Pharma Pro |
| Fizdi-H 2%w/w/1%w/w CreamRegistry verified | Fusidic Acid + Hydrocortisone HCl | — | — | — | 137060Official source ↗ | No indexed price | — | — |
| Fordim | Levofloxacin | 250 mg | Tablet | 10's | 078784 | PKR 291.22 | PKR 29.12/tablet | 🔒 Pharma Pro |
| Fordim | Levofloxacin | 500 mg | Tablet | 10's | 078785 | PKR 621.27 | PKR 62.13/tablet | 🔒 Pharma Pro |
| Glimfempa | Empagliflozin | 10 mg | Tablet | 14's | 121428 | PKR 752.78 | PKR 53.77/tablet | 🔒 Pharma Pro |
| Glimfempa | Empagliflozin | 25 mg | Tablet | 14's | 121429 | PKR 901.01 | PKR 64.36/tablet | 🔒 Pharma Pro |
| Harod | Ciprofloxacin | 250 mg | Tablet | 10's | 078786 | PKR 252.39 | PKR 25.24/tablet | 🔒 Pharma Pro |
| Harod | Ciprofloxacin | 500 mg | Tablet | 10's | 078787 | PKR 417.41 | PKR 41.74/tablet | 🔒 Pharma Pro |
| Hedqin 40 | Dihydroartemisinin + Piperaquine | 40 mg + 320 mg | Tablet | 8's | 109415 | PKR 676.29 | PKR 84.54/tablet | 🔒 Pharma Pro |
| Imlax | Cephalexin | 250 mg | Capsule | 12's | 101554 | PKR 188.36 | PKR 15.70/capsule | 🔒 Pharma Pro |
| Imlax | Cephalexin | 125 mg/5 mL | Suspension | 60ml | 101555 | PKR 108.94 | PKR 1.82/mL | 🔒 Pharma Pro |
| Imlax | Cephalexin | 250 mg/5 mL | Suspension | 60ml | 101556 | PKR 188.36 | PKR 3.14/mL | 🔒 Pharma Pro |
| Kezidime | Ceftazidime | 500 mg | Injection | 1's | 064694 | PKR 255.31 | PKR 255.31/vial/unit | 🔒 Pharma Pro |
| Kezidime | Ceftazidime | 250 mg | Injection | 1's | 064700 | PKR 167.85 | PKR 167.85/vial/unit | 🔒 Pharma Pro |
| Kezidime-A 2.5gm Injection I.VRegistry verified | Avibactum Sodium eq. to Avibactum, Ceftazidime | — | — | — | 135408Official source ↗ | No indexed price | — | — |
| Lamtrig | Lamotrigine = | 100 mg | Tablet | 30's | 109416 | PKR 1,081.10 | PKR 36.04/tablet | 🔒 Pharma Pro |
All 33 Daneen Pharma brands in Pakistan
- Ardan Artesunate · 120 mg injection, 30 mg injection, 60 mg injection
- Blucef Ceftriaxone · 1 g injection, 2 g injection, 250 mg injection
- Canon Vancomycin · 500 mg injection
- Confentrin Artemether + Lumefantrine · 120 mg + 120 mg tablet, 40 mg + 240 mg tablet
- Danclave Aciclovir · 200 mg tablet, 400 mg tablet, 800 mg tablet
- Danletro Letrozole · 2.5 mg tablet
- Dprofen Ibuprofen · 600 mg/100 mL infusion
- Drisper Disintegranting Risperidone · 4 mg tablet
- Erbivir Entecavir · 0.5 mg tablet, 1 mg tablet
- Fordim Levofloxacin · 250 mg tablet, 500 mg tablet
- Glimfempa Empagliflozin · 10 mg tablet, 25 mg tablet
- Harod Ciprofloxacin · 250 mg tablet, 500 mg tablet
- Hedqin 40 Dihydroartemisinin + Piperaquine · 40 mg + 320 mg tablet
- Imlax Cephalexin · 125 mg/5 mL suspension, 250 mg capsule, 250 mg/5 mL suspension
- Kezidime Ceftazidime · 250 mg injection, 500 mg injection
- Lamtrig Lamotrigine = · 100 mg tablet, 150 mg tablet, 200 mg tablet
- LZL Linezolid · 400 mg tablet, 600 mg tablet
- Moxdan Moxifloxacin · 400 mg tablet
- Nadsar-A Telmisartan + Amlodipine · 10 mg + 10 mg tablet, 40 mg + 10 mg tablet, 5 mg + 5 mg tablet
- Nadsar-H Telmisartan + Hydrochlorothiazide · 12.5 mg + 12.5 mg tablet, 40 mg + 12.5 mg tablet
- Olmepra Omeprazole · 20 mg capsule, 40 mg capsule
- Otaks Cefotaxime · 1 g injection, 250 mg injection, 500 mg injection
- Qrenia XR Quetiapine · 150 mg tablet, 300 mg tablet, 400 mg tablet
- Racibac Piperacillin + tazobactam · 2 g + 0.25 g injection, 4 g + 0.5 g injection
- Remcer Meropenem · 1 g injection, 500 mg injection
- Rondisat Ondansetron · 4 mg tablet, 8 mg tablet
- Roxdan Cefuroxime · 250 mg injection, 750 mg injection
- Saltam Levetiracetam · 1000 mg tablet, 250 mg tablet, 500 mg tablet
- Sifrenia Clozapine · 25 MG tablet
- VGC Valganciclovir · 450 mg tablet
- Wazit Azithromycin · 250 mg tablet, 550 mg tablet
- Xineen Cefixime · 100 mg/5 mL suspension, 200 mg/5 mL suspension, 400 mg capsule
- Xinther Clarithromycin · 250 mg tablet, 250 mg/5 mL suspension, 500 mg injection
Daneen Pharma: common questions
How many products does Daneen Pharma have in Pakistan?
Daneen Pharma (Pvt) Ltd has 93 registered medicine presentations in Pakistan, sold under 33 brands and covering 33 generic medicines.
What are the main brands of Daneen Pharma?
By number of registered strengths and packs, its largest brands are Nadsar-A (Telmisartan + Amlodipine), Saltam (Levetiracetam), Blucef (Ceftriaxone), Xinther (Clarithromycin) and Erbivir (Entecavir). This is not a sales ranking.
Which therapy areas does Daneen Pharma cover?
The most products are in Anti-infectives (52), CNS & mental health (18), Cardiovascular (13), Gastrointestinal & hepatology (5) and Oncology & immunology (2).
Where can I see Daneen Pharma medicine prices?
Open any brand in the list above for its official DRAP price, pack sizes, price history and other brands of the same medicine.
MedInfoBase company-intelligence methodology
This page is generated from MedInfoBase medicine, generic, company, price and official-source records. Unverified third-party discovery records are retained internally for coverage auditing and are not published as company registrations. Portfolio leaders are ranked by presentation depth, not sales. Price-position metrics are calculated from current official-source prices normalized to compatible units and compared only against like-for-like products with the same generic, stated strength and dosage form.
Not currently included: sales volume, revenue by brand, market share, prescription volume or best-selling rankings. MedInfoBase will display those only when supported by a defensible licensed, public or company-verified source.
Cite this record
Manufacturer recordRecords change over time. Please cite the access date so readers can locate the version you used.